Shares of Jazz Pharmaceuticals plc – (NASDAQ:JAZZ) have been assigned a consensus recommendation of “Buy” from the fourteen ratings firms that are covering the company, Analyst Ratings Net reports. Four research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 12-month price target […]
